AI-driven platform for precision monitoring in transplantation and cancer
OUR PLATFORM
kalacura-AI™ is a molecular diagnostics company developing AI-enabled non-invasive technologies for precision monitoring in transplantation and oncology.
The platform is supported by proprietary intellectual property and patent filings covering the underlying platform architecture and analytical framework.
Initial clinical development is focused on organ transplantation, with broader applications in oncology and systemic disease.
The platform is currently undergoing clinical validation, with translational studies underway and regulatory pathways toward clinical deployment being developed in parallel.
Our
company ethos
We believe medicine should see the whole patient, not just their mutations.
Our mission is to enable earlier and more precise insight into disease, helping clinicians act sooner and improve patient outcomes.
